Lin-fiting γc expression differentially affects signaling via the interleukin (IL)-7 and IL-15 receptors

被引:12
作者
Smyth, Christine M.
Ginn, Samantha L.
Deakin, Claire T.
Logan, Grant J.
Alexander, Ian E.
机构
[1] Childrens Hosp, Gene Therapy Res Unit, Westmead, NSW 2145, Australia
[2] Univ Sydney, Discipline Paediat & Child Hlth, Sydney, NSW 2006, Australia
关键词
D O I
10.1182/blood-2006-11-055442
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
X-linked severe combined immunodeficiency (SCID-X1) results from mutations in the IL2RG gene, which encodes the common gamma chain (gamma c) of the receptors for interleukin (IL)-2, 4, 7, 9, 15, and 21. Affected infants typically lack T and natural killer (NK) cells as a consequence of loss of signaling via the IL-7 receptor (IL-7R) and the IL-15R, respectively. In some infants, however, autologous NK cells are observed despite failure of T-cell ontogeny. The mechanisms by which mutations in gamma c differentially impact T- and NK-cell ontogeny remain incompletely understood. We used SCID-X1 patient-derived EBV-transformed B cells to test the hypothesis that the IL-15R-mediated signaling is preferentially retained as gamma c expression becomes limiting. Signal transduction via the IL-15R was readily detected in control EBV-transformed B cells, and via the IL-7R when modified to express IL-7R alpha. Under the same experimental conditions, patient-derived EBV-transformed B cells expressing trace amounts of gamma c proved incapable of signal transduction via the IL-7R while retaining the capacity for signal transduction via the IL-15R. An equivalent result was obtained in ED-7R cells modified to express varying levels of gamma c. Collectively, these results confirm that signal transduction via the IL-15R, and hence NK ontogeny, is preferentially retained relative to the IL-7R as gamma c expression becomes limiting.
引用
收藏
页码:91 / 98
页数:8
相关论文
共 35 条
[1]  
ANDERSON DM, 1995, J BIOL CHEM, V270, P29862
[2]   Characterization and analysis of the proximal Janus kinase 3 promoter [J].
Aringer, M ;
Hofmann, SR ;
Frucht, DM ;
Chen, M ;
Centola, M ;
Morinobu, A ;
Visconti, R ;
Kastner, DL ;
Smolen, JS ;
O'Shea, JJ .
JOURNAL OF IMMUNOLOGY, 2003, 170 (12) :6057-6064
[3]   Chance or necessity? Insertional mutagenesis in gene therapy and its consequences [J].
Baum, C ;
von Kalle, C ;
Staal, FJT ;
Li, ZX ;
Fehse, B ;
Schmidt, M ;
Weerkamp, F ;
Karlsson, S ;
Wagemaker, G ;
Williams, DA .
MOLECULAR THERAPY, 2004, 9 (01) :5-13
[4]   Human severe combined immunodeficiency: Genetic, phenotypic, and functional diversity in one hundred eight infants [J].
Buckley, RH ;
Schiff, RI ;
Schiff, SE ;
Markert, ML ;
Williams, LW ;
Harville, TO ;
Roberts, JL ;
Puck, JM .
JOURNAL OF PEDIATRICS, 1997, 130 (03) :378-387
[5]   Role of interleukin-2 (IL-2), IL-7, and IL-15 in natural killer cell differentiation from cord blood hematopoietic progenitor cells and from gamma c transduced severe combined immunodeficiency XI bone marrow cells [J].
CavazzanaCalvo, M ;
HaceinBey, S ;
Basile, GD ;
DeCoene, C ;
Selz, F ;
LeDeist, F ;
Fischer, A .
BLOOD, 1996, 88 (10) :3901-3909
[6]   A third-generation lentivirus vector with a conditional packaging system [J].
Dull, T ;
Zufferey, R ;
Kelly, M ;
Mandel, RJ ;
Nguyen, M ;
Trono, D ;
Naldini, L .
JOURNAL OF VIROLOGY, 1998, 72 (11) :8463-8471
[7]   Interleukin 15: biology and relevance to human disease [J].
Fehniger, TA ;
Caligiuri, MA .
BLOOD, 2001, 97 (01) :14-32
[8]   Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences [J].
Follenzi, A ;
Ailles, LE ;
Bakovic, S ;
Geuna, M ;
Naldini, L .
NATURE GENETICS, 2000, 25 (02) :217-+
[9]  
Ginn Samantha L, 2004, Hum Mutat, V23, P522
[10]   Treatment of an infant with X-linked severe combined immunodeficiency (SCID-X1) by gene therapy in Australia [J].
Ginn, SL ;
Curtin, JA ;
Kramer, B ;
Smyth, CM ;
Wong, M ;
Kakakios, A ;
McCowage, GB ;
Watson, D ;
Alexander, SI ;
Latham, M ;
Cunningham, SC ;
Zheng, ML ;
Hobson, L ;
Rowe, PB ;
Fischer, A ;
Cavazzana-Calvo, M ;
Hacein-Bey-Abina, S ;
Alexander, IE .
MEDICAL JOURNAL OF AUSTRALIA, 2005, 182 (09) :458-463